Industry round-up: Advanced Sterilization Products, Merge, TeraMedica
Advanced Sterilization Products, owned by Johnson & Johnson, has received U.S. FDA cleared for the EvoTech Endoscope Cleaner and Reprocessor (ECR), a washer/disinfection system for endoscopes designed to eliminate labor-intensive manual cleaning. This system provides an automated endoscope cleaning process that is comparable to professional society guidelines for manual cleaning. The EvoTech ECR, as cleared by the FDA, is indicated for use with high-level disinfectant CIDEX OPA Concentrate and an enzymatic detergent (CIDEZYME GI) to achieve cleaning and high-level disinfection of heat sensitive (>60° C) semi-critical endoscopes. Manual cleaning of medical devices (endoscopes) is not required prior to placement in the EvoTech System when selecting those cycles that contain a wash stage. EvoTech ECR will be available for purchase in first half of 2007, the company said.
Merge Healthcare announced its Q3 2006 financial results with net sales of approximately $14.0 million, a decrease when compared to net sales of approximately $35.0 million for the same period in 2005. The company's Q3 2006 net loss was $10.8 million. Net income for Q3 2005 was $9.6 million. As for Merge’s year-to-date results, net sales totaled $61.9 million, up from $57.1 million reported for the first nine months of 2005. The company's net loss for the first nine months of 2006 was $231.4 million. The net loss for the same period in 2005 was $5.4 million.
TeraMedica Healthcare Technology announced plans to contribute to an open source DICOM toolkit developed by a worldwide team of engineers. “TeraMedica is planning on dedicating resources to the continued success of the DCM4CHE project” said Jim Prekop, TeraMedica CEO. “It makes good sense for the healthcare industry to have multiple vendors collaborating on something as fundamental as a DICOM toolkit.” The open source DCM4CHE project was started in 2001 with the purpose of providing a high quality, high performance implementation of the DICOM standard and IHE actors using the Java programming language. The project has matured throughout the years, and its products are used by many institutions, projects, and vendors worldwide.
Merge Healthcare announced its Q3 2006 financial results with net sales of approximately $14.0 million, a decrease when compared to net sales of approximately $35.0 million for the same period in 2005. The company's Q3 2006 net loss was $10.8 million. Net income for Q3 2005 was $9.6 million. As for Merge’s year-to-date results, net sales totaled $61.9 million, up from $57.1 million reported for the first nine months of 2005. The company's net loss for the first nine months of 2006 was $231.4 million. The net loss for the same period in 2005 was $5.4 million.
TeraMedica Healthcare Technology announced plans to contribute to an open source DICOM toolkit developed by a worldwide team of engineers. “TeraMedica is planning on dedicating resources to the continued success of the DCM4CHE project” said Jim Prekop, TeraMedica CEO. “It makes good sense for the healthcare industry to have multiple vendors collaborating on something as fundamental as a DICOM toolkit.” The open source DCM4CHE project was started in 2001 with the purpose of providing a high quality, high performance implementation of the DICOM standard and IHE actors using the Java programming language. The project has matured throughout the years, and its products are used by many institutions, projects, and vendors worldwide.